Highly Potent Drugs

Sep 15, 2010
Equipment and Processing Report
By Pharmaceutical Technology Editors
US Pharmacopeia apparatuses for testing the dissolution of transdermal drugs produce good, reproducible results. Yet some scientists believe that further modifications could improve the instruments? suitability for this application.
Sep 01, 2010
Pharmaceutical Technology Europe
The main advantage of outsourcing highly potent API (HPAPI) manufacture is that it eliminates the need to invest in expensive containment infrastructure, which can also be complex to engineer, install and maintain.
Aug 18, 2010
Equipment and Processing Report
By Pharmaceutical Technology Editors
Making highly potent active pharmaceutical ingredients (HPAPIs) can be costly because the process often requires equipment specialized to achieve containment and extra attention to safety concerns. Pharmaceutical professionals may wonder whether disposable components, which have reduced the cost of some operations, might be appropriate in the manufacture of HPAPIs.
Sep 01, 2009
Pharmaceutical Technology
By Pharmaceutical Technology Editors
The author describes the approach taken to develop a facility dedicated to handling potent and cytotoxic drug substances.
Jul 02, 2009
Pharmaceutical Technology
High-potency manufacturing of active pharmaceutical ingredients is a growing and specialized capability.
Jun 02, 2009
Pharmaceutical Technology
By Pharmaceutical Technology Editors
Pharmacosomes can pass through biomembranes efficiently and possess several advantages over traditional vesicular drug-delivery systems.
Sep 02, 2008
Pharmaceutical Technology
Sterile manufacturing may be the next aspect of pharmaceutical manufacturing to consider in the continuous process paradigm.
Sep 01, 2008
Pharmaceutical Technology
By Pharmaceutical Technology Editors
The author explains the planning, equipment, and facility design requried for manufacturing HPAPIs and specialized requirements for handling these compounds.
Jul 10, 2008
ePT--the Electronic Newsletter of Pharmaceutical Technology
By Pharmaceutical Technology Editors
The European Pharmacopeia Commission has published the General Information chapter "Potentially Genotoxic Impurities and European Pharmacopoeia Monographs on Substances for Human Use" in the July 2008 edition of PharmEuropa.
Apr 01, 2008
Pharmaceutical Technology
By Pharmaceutical Technology Editors
Liquid and semisolid encapsulation using two-piece hard capsules is an ideal drug delivery approach for highly potent compounds and poorly water-soluble drugs. The authors detail the factors to reduce risk when designing and operating a facility for secondary manufacturing of highly potent drugs.
native1_300x100
lorem ipsum